Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38238
CAS Number:
144875-48-9
Resquimod
Purity:
≥ 98%
Synonym(s):
1-[4-Amino-2-(etoximetil)-1H - imidazo[4,5-c]quinolin-1-il]-2-metilpropan-2-ol, a-dimetil- 1H -imidazo(4,5-c)quinolina-1-etanol
Documents
$50.28 /25 mg
Tamaño
Request Bulk Quote
Product Information

Conservar bajo gas inerte.

Synonyms
1-[4-Amino-2-(etoximetil)-1H - imidazo[4,5-c]quinolin-1-il]-2-metilpropan-2-ol, a-dimetil- 1H -imidazo(4,5-c)quinolina-1-etanol
CAS Number
144875-48-9
Purity
≥ 98%
Molecular Formula
C17H22N4O2
Molecular Weight
314.39
MDL Number
MFCD00937759
PubChem ID
159603
Melting Point
192 - 194 °C (Literatura)
Appearance
Sólido blanquecino
Conditions
Conservar a < -20 °C
General Information
Synonyms
1-[4-Amino-2-(etoximetil)-1H - imidazo[4,5-c]quinolin-1-il]-2-metilpropan-2-ol, a-dimetil- 1H -imidazo(4,5-c)quinolina-1-etanol
CAS Number
144875-48-9
Purity
≥ 98%
Molecular Formula
C17H22N4O2
Molecular Weight
314.39
MDL Number
MFCD00937759
PubChem ID
159603
Melting Point
192 - 194 °C (Literatura)
Appearance
Sólido blanquecino
Conditions
Conservar a < -20 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Resiquimod is widely utilized in research focused on:

  • Topical Immunotherapy: It is used in creams for treating skin conditions like actinic keratosis and superficial basal cell carcinoma, enhancing local immune response.
  • Vaccine Adjuvant: Resiquimod acts as an adjuvant in vaccines, improving the effectiveness of the immune response against various pathogens.
  • Antiviral Applications: It shows promise in treating viral infections, particularly in enhancing the immune system's ability to combat viruses like HPV.
  • Research in Oncology: Its immunomodulatory properties are being explored in cancer therapies, potentially improving outcomes by stimulating immune activity against tumors.
  • Dermatological Research: Used in studies to understand skin immune responses and develop new treatments for inflammatory skin diseases.

Citas